Brain Mechanisms of Emotion and Motivation: A Mind-Body Study

Healthy Clinical Trial

— MIDAS  

Official title:

Brain Mechanisms of Emotion and Motivation: A Mind-Body Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01850472
• Other study ID #: 2012P001786
• Secondary ID: 5R01MH068376
• Status: Completed
• Start date: March 2013
• Est. completion date: January 2016

Study information

• Verified date: May 2018
• Source: Mclean Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this research study is to investigate how the brain processes emotions, and the way these processes affect behavior. Specifically, we hypothesize that individual differences in reward responsiveness will correlate with differential activation in mesolimbic regions of the brain and predict future wellbeing in follow-up interviews.

Description:

The purpose of this research study is to investigate how the brain processes emotions, and the way these processes affect behavior. Specifically, we hypothesize that individual differences in reward responsiveness will correlate with differential activation in mesolimbic regions of the brain and predict future wellbeing in follow-up interviews. Participating in this study involves up to two sessions and up to 7.5 hours. In the present observational study, each participant will be exposed to the same experimental procedure.

Visit 1 will take about 4.5 hours, from 12pm to 4:30pm. The visit will take place at the Center for Depression, Anxiety and Stress at McLean. During this visit, a clinical interviewer will conduct a diagnostic SCID interview to ensure that participants qualify to take part in this research study. Participants will then complete several tasks. These tasks include several different "game-like" situations and arithmetic riddles, all of which are simple but require participants to work hard and remain alert for an extended period of time. The goal during these games is to earn as much money as you can or to avoid losing money. Participants will do so by responding (pressing a keyboard button) quickly and accurately. These tasks are intended as assessment tools, and are not a form of therapy or intervention. In addition, we will test participants' ability to keep their hand in cold water. Participants will also be asked to provide blood (via a saline IV) and saliva samples at different times during this session, and we will also conduct urine drug and pregnancy tests. The IV will be in place for a total of around 3 hours, and is used to reduce discomfort from multiple blood draws.

Visit 2 will take place at the McLean Imaging Center at McLean Hospital. During the first part of the session, the fMRI scanner will take structural pictures of brain anatomy. Next, additional images will be obtained while participants complete several different "game-like" tasks, similar to the tasks performed in visit 1. Again, these tasks are intended as assessment tools, and are not a form of therapy or intervention. The whole fMRI session will last up to about 2.5 hours; participants will spend about 1.5 hours in the fMRI machine, and about a half-an-hour completing questionnaires and providing saliva samples. Prior to the fMRI scan, another urine sample will be obtained to check for drugs which may interfere with the experiment.

After the second study session is complete, participants will be re-contacted through the internet every four weeks for a total of six months, to complete some questionnaires. At the end of six months, participants will be asked to return to McLean to complete an in-person interview. This follow-up period is purely observational and not intended to assess health outcomes, as there is no intervention in this study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 88
• Est. completion date: January 2016
• Est. primary completion date: January 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Absence of medical, neurological, and psychiatric illness (including alcohol and substance abuse), as assessed by subject history and a structured clinical interview (SCID-I/NP)

• Written informed consent

• Both genders and all ethnic origins, age between 18 and 45

• Right-handed

• Absence of any medications for at least 3 weeks

• Absence of pregnancy as determined by completion of a negative urine pregnancy test prior to the MRI scan

• Fluent English speaker

• Absence of current drug use (cocaine, cannabinoids, opiates, amphetamines, methamphetamines, phencyclidine, MDMA, benzodiazepines, methadone, oxycodone, tricyclic antidepressants, and barbiturates) as assessed by a urine drug test.

Exclusion Criteria:

• Pregnant or currently breast-feeding women or any woman of childbearing potential who is seeking to become pregnant or suspects that she may be pregnant.

• History or current serious or unstable medical illness, including cardiovascular, hepatic, renal, respiratory, endocrine, neurologic or hematologic disease

• History of seizure disorder

• Failure to meet standard fMRI safety requirements

• History of head injury

• History or current diagnosis of any DSM-IV psychiatric illnesses; Presence of a DSM-IV psychiatric illness within a first-degree relative

• History of cocaine or stimulant use (e.g., amphetamine, cocaine, methamphetamine)

• History of use of dopaminergic drugs (including methylphenidate)

• History or current diagnosis of dementia

• Patients with mood congruent or mood incongruent psychotic features

• History or current use of any psychiatric medication

• Current use of any drug or herbal supplement with well-characterized psychotropic effects (e.g. St. John's wort)

• Clinical or laboratory evidence of hypothyroidism

• Diabetes with poor glucose control

• Currently taking medication that affects blood flow, e.g. certain blood pressure medications

• Evidence of significant inconsistencies in self-report.

Related Conditions & MeSH terms

• Anhedonia
• Healthy
• Stress

Locations

Country	Name	City	State
United States	McLean Hospital	Belmont	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Mclean Hospital	National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Brain Activity during Instrumental Learning Task	Functional magnetic resonance imaging (fMRI) data are acquired while participants perform the instrumental learning task. fMRI data allows us to measure aspects of brain activity.	2 hour long scan during session 2
Primary	Change in Behavioral Performance in Instrumental Learning Task	The instrumental learning task is designed to measure participant learning from reward and punishment. It will be administered twice during session 1 to calculate changes in reward and punishment sensitivity.	Administered during session 1 twice for a total of 10 minutes
Primary	Behavioral performance in Effort-Expenditure for Rewards Task	The instrumental learning task is designed to measure reward sensitivity.	15 minute task during session 2
Primary	Change in Questionnaire Data	At all sessions participants will fill out self-report questionnaires regarding aspects of mood and affect, demographics, caffeine and alcohol consumption, etc. Questionnaires will be completed on paper forms or through the electronic data entry system "RedCap Survey", a HIPPAA compliant secure and encrypted online database. We will use these data to assess changes in participant behavior.	Administered continuously during the two study sessions (total 7 hours); follow-up questionnaires sent out every 2 weeks for a total of 4 months
Primary	Change in Behavioral Performance in Probabilistic Reward Task	The probabilistic reward task is designed to measure sensitivity to reward and reward learning. It will be administered three times during session 1 to calculate changes in reward and punishment sensitivity.	Given three times during session 1 for a total of 35 minutes
Primary	Life Events and Difficulties (LEDS) interview	The LEDS interview is designed to assess life experiences and emotional responses.	6 months after completion of session 2
Primary	Change in salivary hormone levels	A total of ten saliva samples will be taken before, during and after the tasks in sessions 1 and 2 to monitor changes in hormone levels.	During sessions 1 and 2 (a total of 7 hours) saliva samples will be repeatedly gathered
Primary	Salivary genetic analysis	One Saliva sample will be gathered from each participant to analyze genetic markers.	5 minute saliva sample gathered at the beginning of session 1
Primary	Change in inflammatory cytokine levels in blood plasma	Blood will be drawn from participants before, during and after the various tasks in session 1. Changes in inflammatory cytokine levels in blood plasma will be measured to gauge physiological responses to tasks.	3 blood samples, each taking 10 minutes, gathered over the course of session 1 for a total of 30 minutes
Primary	Behavioral Performance in Instrumental Learning Task	The instrumental learning task is designed to measure participant learning from reward and punishment.	Administered in session 2 during two hour long scan
Secondary	Change in Behavioral performance in Reaction Time task	The Reaction Time task is designed to control for individual differences in reaction time and fatigue during the session.	Given 3 times during session 1 for a total of 9 minutes